Prefrontal Structure Varies as a Function of Pain Symptoms in Chronic Fatigue Syndrome.
van der Schaaf, Marieke E, De Lange, Floris P, Schmits, Iris C et al. · Biological psychiatry · 2017 · DOI
Quick Summary
This study examined brain structure in 89 women with ME/CFS using brain imaging. Researchers found that the amount of pain a patient experiences—not fatigue—was the strongest predictor of changes in a specific brain region called the dorsolateral prefrontal cortex. People with more pain showed smaller brain volume and lower levels of brain chemicals in this region, even after accounting for fatigue, depression, and physical activity.
Why It Matters
This finding challenges the assumption that fatigue drives brain changes in ME/CFS and highlights pain as an important neurobiological feature deserving research focus. Understanding that pain—rather than fatigue alone—correlates with specific brain alterations may help researchers develop targeted interventions and improve how we conceptualize ME/CFS heterogeneity.
Observed Findings
Pain severity was the strongest predictor of reduced gray matter volume in the left dorsolateral prefrontal cortex, independent of fatigue severity.
Pain severity was associated with reduced NAA/Cr ratios (a marker of neuronal health) in the left dorsolateral prefrontal cortex.
No significant global gray matter volume differences were found between CFS patients and healthy controls.
Reduced brain volume and neuronal markers in this region correlated with pain even after controlling for depression, physical activity, and psychomotor speed.
Fatigue severity alone did not independently predict brain morphology alterations in the dorsolateral prefrontal cortex.
Inferred Conclusions
Pain symptoms, rather than fatigue, are the primary driver of prefrontal cortex alterations in ME/CFS patients.
ME/CFS as a diagnostic entity (by CDC criteria) is not reliably associated with global brain volume reduction; symptom-specific features like pain are more neurobiologically meaningful.
The dorsolateral prefrontal cortex shows pain-related neurochemical and structural changes in ME/CFS that may reflect altered pain processing or regulation.
Remaining Questions
Does pain cause these brain changes, or do pre-existing brain alterations predispose individuals to develop chronic pain?
What This Study Does Not Prove
This study does not establish causation—it cannot determine whether pain causes the brain changes, brain changes cause pain, or whether both result from an underlying mechanism. The cross-sectional design prevents conclusions about whether these brain alterations develop before, during, or after pain onset. Additionally, findings are limited to women and may not generalize to men with ME/CFS.
Do these prefrontal alterations differ between ME/CFS patients with and without pain, and do they change over time with pain resolution or worsening?
How do these findings in women generalize to men with ME/CFS, and what mechanisms underlie the pain-specific rather than fatigue-specific brain changes?
What is the functional significance of reduced NAA/Cr in the dorsolateral prefrontal cortex—does it reflect neuronal loss, metabolic dysfunction, or altered glial activity?